• 1451 Citations
  • 20 Scopus h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2000 2019

  • 1451 Citations
  • 20 Scopus h-Index
  • 61 Article
Filter
Article
2019
12 Citations (Scopus)

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & de Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 86-94 9 p.

Research output: Contribution to journalArticle

Amenorrhea
Breast Neoplasms
Survival
Hormones
Therapeutics

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, Weinshilboum, R. M., Jan 1 2019, In : Clinical pharmacology and therapeutics.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
1 Citation (Scopus)
Technetium Tc 99m Sestamibi
Molecular Imaging
Breast
Breast Neoplasms
Drug Therapy

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Hormones
Breast Neoplasms
Disease-Free Survival
Neoplasms

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab
2018

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

Nurses
Workload
Safety
Drug Therapy
Nursing Staff
8 Citations (Scopus)

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Yu, J., Qin, B., Moyer, A., Nowsheen, S., Liu, T., Qin, S., Zhuang, Y., Liu, D., Lu, S. W., Kalari, K. R., Visscher, D. W., Copland, J. A. III., McLaughlin, S. A., Moreno Aspitia, A., Northfelt, D. W., Gray, R. J., Lou, Z., Suman, V. J., Weinshilboum, R. M., Boughey, J. C. & 2 others, Goetz, M. P. & Wang, L. M., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2376-2388 13 p.

Research output: Contribution to journalArticle

decitabine
Triple Negative Breast Neoplasms
Methyltransferases
DNA
Biomarkers

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Moreno Aspitia, A., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Breast Neoplasms
Research Design
Therapeutics
Biomarkers
8 Citations (Scopus)

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

Lambertini, M., Martel, S., Campbell, C., Guillaume, S., Hilbers, F. S., Schuehly, U., Korde, L., Azim, H. A., Di Cosimo, S., Tenglin, R. C., Huober, J., Baselga, J., Moreno Aspitia, A., Piccart-Gebhart, M., Gelber, R. D., de Azambuja, E. & Ignatiadis, M., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Breast Neoplasms
Pregnancy
Therapeutics
Down Syndrome
2017
21 Citations (Scopus)

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

Freedman, R. A., Foster, J. C., Seisler, D. K., Lafky, J. M., Muss, H. B., Cohen, H. J., Mandelblatt, J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Cirrincione, C., Moreno Aspitia, A., Kimmick, G., Jatoi, A. & Hurria, A., Feb 1 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 4, p. 421-431 11 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Odds Ratio
Therapeutics
Withholding Treatment
Clinical Protocols

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, SA., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & O’Shaughnessy, J., Sep 7 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-2 2 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Breast Neoplasms
Neoplasm Metastasis
Survival
Brain
10 Citations (Scopus)

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Yu, J., Qin, B., Moyer, A., Sinnwell, J. P., Thompson, K. J., Copland, J. A. III., Marlow, L. A., Miller, J. L., Yin, P., Gao, B., Minter-Dykhouse, K., Tang, X., McLaughlin, S. A., Moreno Aspitia, A., Schweitzer, A., Lu, Y., Hubbard, J., Northfelt, D. W., Gray, R. J., Hunt, K. & 10 others, Conners, A. L., Suman, V. J., Kalari, K. R., Ingle, J. N., Lou, Z., Visscher, D. W., Weinshilboum, R. M., Boughey, J. C., Goetz, M. P. & Wang, L. M., Dec 6 2017, In : Breast cancer research : BCR. 19, 1, 1 p.

Research output: Contribution to journalArticle

Heterografts
Breast Neoplasms
Biopsy
Drug Therapy
Neoplasms
7 Citations (Scopus)

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial

Twelves, C., Cortés, J., O'Shaughnessy, J., Awada, A., Perez, E. A., Im, SA. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & Rugo, H. S., May 1 2017, In : European Journal of Cancer. 76, p. 205-215 11 p.

Research output: Contribution to journalArticle

Quality of Life
Breast Neoplasms
Physicians
Therapeutics
Health Status
26 Citations (Scopus)

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial

Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J., Cufer, T., Simon, S. D., Salman, P., Toi, M., Harris, L., Gralow, J., Keane, M., Moreno Aspitia, A., Piccart-Gebhart, M. & De Azambuja, E., May 1 2017, In : Journal of Clinical Oncology. 35, 13, p. 1421-1429 9 p.

Research output: Contribution to journalArticle

Metformin
Insulin
Breast Neoplasms
Disease-Free Survival
Hormones
3 Citations (Scopus)

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)

Mehrotra, S., Sharma, M. R., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno Aspitia, A., Lad, T. E., Valasco, M., Overmoyer, B., Rugo, H., Ratain, M. J. & Gobburu, J. V., Jun 15 2017, (Accepted/In press) In : AAPS Journal. p. 1-13 13 p.

Research output: Contribution to journalArticle

Peripheral Nervous System Diseases
Paclitaxel
Leukemia
Breast Neoplasms
Drug Therapy
16 Citations (Scopus)

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, SA., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & O’Shaughnessy, J., Jun 13 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-13 13 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Metastasis
Brain Neoplasms
Survival
Brain
6 Citations (Scopus)

Regional Nodal Irradiation after Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis from the ALTTO Trial

Gingras, I., Holmes, E., De Azambuja, E., Nguyen, D. H. A., Izquierdo, M., Zujewski, J. A., Inbar, M., Naume, B., Tomasello, G., Gralow, J. R., Wolff, A. C., Harris, L., Gnant, M., Moreno Aspitia, A., Piccart, M. J. & Azim, H. A., Aug 1 2017, In : Journal of the National Cancer Institute. 109, 8, djw331.

Research output: Contribution to journalArticle

Segmental Mastectomy
Disease-Free Survival
Breast Neoplasms
Lymph Nodes
Recurrence
1 Citation (Scopus)

Rifaximin for pertuzumab-related GI toxicities

Soyano, A. E., Reynolds, G., Moreno Aspitia, A. & Chumsri, S., Aug 8 2017, In : Frontiers in Oncology. 7, AUG, p. 168 1 p.

Research output: Contribution to journalArticle

rifaximin
Abdominal Pain
Diarrhea
Antidiarrheals
Combination Drug Therapy
15 Citations (Scopus)

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Goetz, M. P., Kalari, K. R., Suman, V. J., Moyer, A., Yu, J., Visscher, D. W., Dockter, T. J., Vedell, P. T., Sinnwell, J. P., Tang, X., Thompson, K. J., McLaughlin, S. A., Moreno Aspitia, A., Copland, J. A. III., Northfelt, D. W., Gray, R. J., Hunt, K., Conners, A., Weinshilboum, R. M., Wang, L. M. & 1 others, Wieben, E. D., Jul 1 2017, In : Journal of the National Cancer Institute. 109, 7, djw306.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Heterografts
Breast Neoplasms
Drug Therapy
Neoplasms
2016
10 Citations (Scopus)

Assessment of tumor heterogeneity, as evidenced by gene expression profiles, pathway activation, and gene copy number, in patients with multifocal invasive lobular breast tumors

Norton, N., Advani, P. P., Serie, D. J., Geiger, X. J., Necela, B. M., Axenfeld, B. C., Kachergus, J. M., Feathers, R. W., Carr, J. M., Crook, J., Moreno Aspitia, A., Anastasiadis, P. Z., Perez, E. A. & Thompson, E. A., Apr 1 2016, In : PLoS One. 11, 4, e0153411.

Research output: Contribution to journalArticle

Lobular Carcinoma
gene dosage
Gene Dosage
Transcriptome
Gene expression
15 Citations (Scopus)

Phase i Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Tan, W., Allred, J. B., Moreno Aspitia, A., Northfelt, D. W., Ingle, J. N., Goetz, M. P. & Perez, E. A., Apr 1 2016, In : Clinical Breast Cancer. 16, 2, p. 82-86 5 p.

Research output: Contribution to journalArticle

letrozole
Breast Neoplasms
Histone Deacetylase Inhibitors
Triple Negative Breast Neoplasms
Maximum Tolerated Dose
2015
5 Citations (Scopus)

A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

Mattison, R., Jumonville, A., Flynn, P. J., Moreno Aspitia, A., Erlichman, C., Laplant, B. & Juckett, M. B., Jul 1 2015, In : Leukemia and Lymphoma. 56, 7, p. 2061-2066 6 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Vascular Endothelial Growth Factor Receptor
Receptor Protein-Tyrosine Kinases
Therapeutics
4 Citations (Scopus)

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors

Necela, B. M., Crozier, J. A., Andorfer, C. A., Lewis-Tuffin, L., Kachergus, J. M., Geiger, X. J., Kalari, K. R., Serie, D. J., Sun, Z., Moreno Aspitia, A., O'Shannessy, D. J., Maltzman, J. D., McCullough, A. E., Pockaj, B. A., Cunliffe, H. E., Ballman, K. V., Thompson, E. A. & Perez, E. A., Apr 30 2015, In : PLoS One. 10, 4, e0127133.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Advani, P., Cornell, L., Chumsri, S. & Moreno Aspitia, A., Sep 22 2015, In : Breast Cancer: Targets and Therapy. 7, p. 321-335 15 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
Biomarkers
Receptor Protein-Tyrosine Kinases
human ERBB2 protein
43 Citations (Scopus)

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): A randomised, open-label, multicentre, phase 3 trial

Perez, E. A., Awada, A., O'Shaughnessy, J., Rugo, H. S., Twelves, C., Im, S. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & Cortes, J., 2015, In : The Lancet Oncology. 16, 15, p. 1556-1568 13 p.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Physicians
irinotecan
Therapeutics
11 Citations (Scopus)

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Ellingson, M. S., Hart, S., Kalari, K. R., Suman, V. J., Schahl, K. A., Dockter, T. J., Felten, S. J., Sinnwell, J. P., Thompson, K. J., Tang, X., Vedell, P. T., Barman, P., Sicotte, H., Eckel-Passow, J. E., Northfelt, D. W., Gray, R. J., McLaughlin, S. A., Moreno Aspitia, A., Ingle, J. N., Moyer, A. & 9 others, Visscher, D. W., Jones, K., Conners, A., McDonough, M., Wieben, E. D., Wang, L. M., Weinshilboum, R. M., Boughey, J. C. & Goetz, M. P., Sep 7 2015, In : Breast Cancer Research and Treatment. 153, 2, p. 435-443 9 p.

Research output: Contribution to journalArticle

Exome
Neoplasm Genes
Breast Neoplasms
Drug Therapy
Genes
14 Citations (Scopus)

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

Crozier, J. A., Advani, P. P., Laplant, B., Hobday, T. J., Jaslowski, A. J., Moreno Aspitia, A. & Perez, E. A., May 18 2015, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

irinotecan
Anthracyclines
Breast Neoplasms
Triple Negative Breast Neoplasms
Therapeutics
78 Citations (Scopus)

Randomized phase III trial of paclitaxel once per week compared with nanoparticle albumin-bound nab-paclitaxel once per week or ixabepilone with bevacizumab as first-line chemotherapy for locally recurrent or metastatic breast cancer: CALGB 40502/NCCTG N063H (Alliance)

Rugo, H. S., Barry, W. T., Moreno Aspitia, A., Lyss, A. P., Cirrincione, C., Leung, E., Mayer, E. L., Naughton, M., Toppmeyer, D., Carey, L. A., Perez, E. A., Hudis, C. & Winer, E. P., Jul 20 2015, In : Journal of Clinical Oncology. 33, 21, p. 2361-2369 9 p.

Research output: Contribution to journalArticle

Paclitaxel
Nanoparticles
Breast Neoplasms
Drug Therapy
Disease-Free Survival
2014
39 Citations (Scopus)

Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines

Crozier, J. A., Swaika, A. & Moreno Aspitia, A., Aug 10 2014, In : World Journal of Clinical Oncology. 5, 3, p. 529-538 10 p.

Research output: Contribution to journalArticle

Anthracyclines
Adjuvant Chemotherapy
Breast Neoplasms
Recurrence
Hematologic Neoplasms
27 Citations (Scopus)

Current strategies for the prevention of breast cancer

Advani, P. & Moreno Aspitia, A., 2014, In : Breast Cancer: Targets and Therapy. 6, p. 59-71 13 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Selective Estrogen Receptor Modulators
Aromatase Inhibitors
Mastectomy
Incidence
2013
20 Citations (Scopus)

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

Crozier, J. A., Moreno Aspitia, A., Ballman, K. V., Dueck, A., Pockaj, B. A. & Perez, E. A., Jul 1 2013, In : Cancer. 119, 13, p. 2447-2454 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Body Mass Index
Neoplasms
Breast Neoplasms
Weights and Measures
12 Citations (Scopus)

RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

Moreno Aspitia, A., Dueck, A., Ghanem-Cañete, I., Patel, T., Dakhil, S., Johnson, D., Franco, S., Kahanic, S., Colon-Otero, G., Tenner, K. S., Rodeheffer, R., McCullough, A. E., Jenkins, R. B., Palmieri, F. M., Northfelt, D. W. & Perez, E. A., Apr 2013, In : Breast Cancer Research and Treatment. 138, 2, p. 427-435 9 p.

Research output: Contribution to journalArticle

Paclitaxel
Breast Neoplasms
Therapeutics
Heart Failure
Safety
30 Citations (Scopus)

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831

Moreno Aspitia, A., Hillman, D. W., Dyar, S. H., Tenner, K. S., Gralow, J., Kaufman, P. A., Davidson, N. E., Lafky, J. M., Reinholz, M. M., Lingle, W. L., Kutteh, L. A., Carney, W. P., Dueck, A. & Perez, E. A., Aug 1 2013, In : Cancer. 119, 15, p. 2675-2682 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Recurrence
Neoplasms
Therapeutics
2012
6 Citations (Scopus)
Translational Medical Research
African Americans
Research
Neoplasms
Multiple Myeloma
12 Citations (Scopus)

Neoadjuvant therapy in early-stage breast cancer

Moreno Aspitia, A., May 2012, In : Critical Reviews in Oncology/Hematology. 82, 2, p. 187-199 13 p.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
Drug Therapy
Cytotoxins
Biological Factors
2011
42 Citations (Scopus)

Cytokeratin-19 and Mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437

Reinholz, M. M., Kitzmann, K. A., Tenner, K., Hillman, D., Dueck, A., Hobday, T. J., Northfelt, D. W., Moreno Aspitia, A., Roy, V., LaPlant, B., Allred, J. B., Stella, P. J., Lingle, W. L. & Perez, E. A., Nov 15 2011, In : Clinical Cancer Research. 17, 22, p. 7183-7193 11 p.

Research output: Contribution to journalArticle

Keratin-19
Circulating Neoplastic Cells
Breast Neoplasms
Gene Expression
Messenger RNA
2 Citations (Scopus)
Breast Neoplasms
Progesterone Receptors
Therapeutics
Estrogen Receptors
Vascular Endothelial Growth Factor A
21 Citations (Scopus)

Patient age and preoperative breast MRI in women with breast cancer: Biopsy and surgical implications

Adkisson, C. D., Vallow, L. A., Kowalchik, K., McNeil, R., Hines, S., Deperi, E., Moreno Aspitia, A., Roy, V., Perez, E. A. & McLaughlin, S. A., Jun 2011, In : Annals of Surgical Oncology. 18, 6, p. 1678-1683 6 p.

Research output: Contribution to journalArticle

Breast
Mastectomy
Magnetic Resonance Imaging
Breast Neoplasms
Biopsy
180 Citations (Scopus)

Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer

Perez, E. A., Suman, V. J., Davidson, N. E., Gralow, J. R., Kaufman, P. A., Visscher, D. W., Chen, B., Ingle, J. N., Dakhil, S. R., Zujewski, J., Moreno Aspitia, A., Pisansky, T. M. & Jenkins, R. B., Dec 1 2011, In : Journal of Clinical Oncology. 29, 34, p. 4491-4497 7 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Disease-Free Survival
Paclitaxel
Survival Rate
1 Citation (Scopus)

The definition of IgM multiple myeloma

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Aug 2011, In : American Journal of Hematology. 86, 8, p. 718-719 2 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Immunoglobulin M
2010
38 Citations (Scopus)

Adjuvant therapy of triple negative breast cancer

Perez, E. A., Moreno Aspitia, A., Thompson, E. A. & Andorfer, C. A., Apr 2010, In : Breast Cancer Research and Treatment. 120, 2, p. 285-291 7 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Taxoids
Anthracyclines
Tubulin
Standard of Care
17 Citations (Scopus)

Clinical overview of sorafenib in breast cancer

Moreno Aspitia, A., May 2010, In : Future Oncology. 6, 5, p. 655-663 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasms
Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Receptor Protein-Tyrosine Kinases
59 Citations (Scopus)

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

Perez, E. A., Patel, T. & Moreno Aspitia, A., Jun 2010, In : Breast Cancer Research and Treatment. 121, 2, p. 261-271 11 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
ixabepilone
Disease-Free Survival
Breast Neoplasms
Therapeutics
50 Citations (Scopus)

IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Nov 2010, In : American Journal of Hematology. 85, 11, p. 853-855 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Immunoglobulin M
Plasma Cells
Bone and Bones
14 Citations (Scopus)

Plasma Cell Dyscrasia Causing Light Chain Tubulopathy Without Fanconi Syndrome

Elliott, M. R., Cortese, C., Moreno Aspitia, A. & Dwyer, J. P., Jun 2010, In : American Journal of Kidney Diseases. 55, 6, p. 1136-1141 6 p.

Research output: Contribution to journalArticle

Fanconi Syndrome
Immunoglobulin Light Chains
Podocytes
Proximal Kidney Tubule
Paraproteinemias
2009
46 Citations (Scopus)
Anthracyclines
Taxoids
Breast Neoplasms
docetaxel
gemcitabine
126 Citations (Scopus)

Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336

Moreno Aspitia, A., Morton, R. F., Hillman, D. W., Lingle, W. L., Rowland, K. M., Wiesenfeld, M., Flynn, P. J., Fitch, T. R. & Perez, E. A., Jan 1 2009, In : Journal of Clinical Oncology. 27, 1, p. 11-15 5 p.

Research output: Contribution to journalArticle

Taxoids
Anthracyclines
Breast Neoplasms
Neoplasms
Therapeutics
55 Citations (Scopus)

Treatment options for breast cancer resistant to anthracycline and taxane

Moreno Aspitia, A. & Perez, E. A., 2009, In : Mayo Clinic Proceedings. 84, 6, p. 533-545 13 p.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
PubMed
Therapeutics
Taxoids
2008
10 Citations (Scopus)

Issues and controversies in the treatment of HER2 positive metastatic breast cancer

Amar, S., Moreno Aspitia, A. & Perez, E. A., May 2008, In : Breast Cancer Research and Treatment. 109, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Patient Selection
Intravenous Immunoglobulins
Proxy
11 Citations (Scopus)
Plasma Cells
Platelet Count
Blood Cells
Stem Cells
Tissue Donors